Our certified medical device product Scarletred®Vision solves the problem of lacking standardization and objectivity in Teledermatology.
In today’s skincare market, there are more treatments than the average person can count. Formulas have been developed for people with dry skin, combination skin, oily skin, severely oily skin, and everything in between. Despite the fact that there is currently a highly diverse skincare market, there’s an extreme lack of objective technology for detecting skin issues. The current visual diagnosis of skin disorders can be limiting, as the same condition on different skin tones can look very different to the human eye. Because the dermatology field relies heavily on visual examinations, this issue can be highly time-consuming, with weak information and results. This, in the end, costs healthcare providers a lot of time and money.
SCARLETRED has designed a digital solution to this visual problem: Scarletred®Vision.
The clinically validated software enables high quality remote skin imaging and analysis in a multitude of skin conditions. Our award winning technology is supplied internationally to biopharma and cosmetics companies, governments, hospitals and clinicians. It is easy to use and enables to deliver better skin care products and health care services faster at significant lower development cost.
Dr. Harald Schnidar
CEO & Founder
Dr. Harald Schnidar is the founder and CEO of the award-winning digital health company SCARLETRED. The company is headquartered in Vienna and recently expanded to the U.S. by establishing a corporation at the reputational Cambridge Innovation Center next to MIT. Dr. Schnidar is the inventor of Scarletred®Vision, a novel technology that is poised to transform the global dermatology market. Before SCARLETRED, he worked in academics and clinical R&D for skin pharmaceuticals. Dr. Harald Schnidar holds a PhD in Genetics from the University of Salzburg.
Clinical proof of concept
EUR 500K Pre-seed
SCARLETRED Holding GmbH in Vienna, Austria
Applications worldwide, granted in first health care markets
Go Silicon Valley at Plug&Play Tech Center (USA)
CE medical device class 1 for Scarletred®Vision
App of the Year Award by Futurezone
EUR 800K AWS Seed
1st in EU (Biopharma)
1st in USA (Medtech)
Global Nr 1 (Cosmetics)
Austrian State Prize "Digital Solution" by
Federal Ministry of Science, Research and Economy (BMWFW)
Crowd investment EUR 600K EUR (Greenrocket)
SCARLETRED Inc in Boston (USA)
Granted in Europe and USA
Boston Landing Zone at CIC (USA)
Young Innovators by WSA United Nations
Granted in Japan, Australia and other markets
ISO 13485 Quality Management System
Top of Styria Award
Tech Start-Up Award